Assessing the Utility of Ultrasound Compared to Cross-Sectional Imaging in the Follow-up of Patients With Renal Cell Carcinoma

Last updated: August 31, 2020
Sponsor: University of Kansas Medical Center
Overall Status: Active - Recruiting

Phase

N/A

Condition

Renal Cell Carcinoma

Cancer/tumors

Carcinoma

Treatment

N/A

Clinical Study ID

NCT04424472
STUDY00145327
  • Ages > 18
  • All Genders

Study Summary

The aim of this study is to determine the utility of renal ultrasonography (US) in the detection of abdominal recurrences after definitive therapy for renal cell carcinoma (RCC) and compare the detection rate to that of cross-sectional imaging.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Patients must be 18 year of age or older.

  • Patients having undergone radical or partial nephrectomy for the indication of renalcell carcinoma.

  • Most recent imaging study must have been either computed tomography (CT) or magneticresonance imaging (MRI).

Exclusion

Exclusion Criteria:

  • Patients with pT4 disease (tumor invades beyond the Gerota fascia: includingcontiguous extension into the ipsilateral adrenal gland).

  • Patients with metastatic disease prior to time of surgery requiring systemictreatment.

  • Patients with another active cancer diagnosis requiring systemic treatment.

  • Patients with contrast allergies.

  • Patients with baseline chronic kidney disease (GFR < 45 ml/min/1.73 m2).

Study Design

Total Participants: 50
Study Start date:
July 17, 2020
Estimated Completion Date:
December 01, 2022

Connect with a study center

  • University of Kansas Health System

    Kansas City, Kansas 66160
    United States

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.